NDC 51662-1314

VASOPRESSIN

Vasopressin

VASOPRESSIN is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Vasopressin, Unspecified.

Product ID51662-1314_7ae1c8c9-7d76-55a8-e053-2991aa0af05b
NDC51662-1314
Product TypeHuman Prescription Drug
Proprietary NameVASOPRESSIN
Generic NameVasopressin
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-11-17
Marketing CategoryNDA / NDA
Application NumberNDA204485
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameVASOPRESSIN, UNSPECIFIED
Active Ingredient Strength20 [USP'U]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1314-1

1 mL in 1 VIAL (51662-1314-1)
Marketing Start Date2018-11-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1314-1 [51662131401]

VASOPRESSIN INJECTION
Marketing CategoryNDA
Application NumberNDA204485
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-11-17
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
VASOPRESSIN, UNSPECIFIED20 [USP'U]/mL

OpenFDA Data

SPL SET ID:7ae1c8c9-7d75-55a8-e053-2991aa0af05b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2103182
  • NDC Crossover Matching brand name "VASOPRESSIN" or generic name "Vasopressin"

    NDCBrand NameGeneric Name
    0517-1020VasopressinVasopressin
    42367-570VASOPRESSINVASOPRESSIN
    43598-085VasopressinVasopressin
    51662-1314VASOPRESSINVASOPRESSIN
    52584-302VASOPRESSINvasopressin
    63323-302VasopressinVASOPRESSIN
    42023-164VasostrictVasopressin
    42023-190VasostrictVasopressin
    42023-219VasostrictVasopressin
    42023-220VasostrictVasopressin
    42023-237VasostrictVasopressin
    71872-7014VasostrictVasopressin
    71872-7264VasostrictVasopressin

    © 2022 FDA.report
    This site is not affiliated with or endorsed by the FDA.